LSV Asset Management
BSTC

LSV Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

LSV Asset Management’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-91,808
Closed -$4.85M – 971
2020
Q3 		$4.85M Buy
91,808
+59,447
+184% +$3.67M 0.01% 539
2020
Q2 		$1.98M Buy
+32,361
New +$1.87M ﹤0.01% 671

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

LSV Asset Management's BSTC Position: Q4 2020 in Review

LSV Asset Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 91,808 shares — an estimated $4.85M sold.

LSV Asset Management first reported a position in BSTC in Q2 2020 and held it in 2 quarters. The position peaked at $4.85M in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • LSV Asset Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • LSV Asset Management sold 91,808 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $4.85M.
  • LSV Asset Management first reported a position in BioSpecifics Technologies Corp. in Q2 2020 and held it in 2 quarters.
  • LSV Asset Management's BioSpecifics Technologies Corp. position peaked at $4.85M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on LSV Asset Management's 13F filing for Q4 2020, filed 8 Feb 2021.